These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 14711340

  • 1. Prospects for vaccine development against Buruli disease.
    Huygen K.
    Expert Rev Vaccines; 2003 Aug; 2(4):561-9. PubMed ID: 14711340
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Buruli ulcer.
    Einarsdottir T, Huygen K.
    Hum Vaccin; 2011 Nov; 7(11):1198-203. PubMed ID: 22048117
    [Abstract] [Full Text] [Related]

  • 6. Recombinant BCG Expressing Mycobacterium ulcerans Ag85A Imparts Enhanced Protection against Experimental Buruli ulcer.
    Hart BE, Hale LP, Lee S.
    PLoS Negl Trop Dis; 2015 Sep; 9(9):e0004046. PubMed ID: 26393347
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Buruli ulcer: the third most common mycobacterial infection.
    Weir E.
    CMAJ; 2002 Jun 25; 166(13):1691. PubMed ID: 12126327
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Mycobacterium ulcerans infection (Buruli ulcer): a case report of the disseminated nonulcerative form.
    Abalos FM, Aguiar J, Guédénon A, Portaels F, Meyers WM.
    Ann Diagn Pathol; 2000 Dec 25; 4(6):386-90. PubMed ID: 11149971
    [Abstract] [Full Text] [Related]

  • 14. [Mycobacterium ulcerans cutaneous infections: Buruli ulcers].
    Josse R, Guedenon A, Darie H, Anagonou S, Portaels F, Meyers WM.
    Med Trop (Mars); 1995 Dec 25; 55(4):363-73. PubMed ID: 8830223
    [Abstract] [Full Text] [Related]

  • 15. [Buruli ulcer--Africa's latest mycobacterial scourge].
    Roupe G.
    Lakartidningen; 2003 Nov 06; 100(45):3596-7. PubMed ID: 14650033
    [Abstract] [Full Text] [Related]

  • 16. A booster vaccination with Mycobacterium bovis BCG does not increase the protective effect of the vaccine against experimental Mycobacterium ulcerans infection in mice.
    Tanghe A, Adnet PY, Gartner T, Huygen K.
    Infect Immun; 2007 May 06; 75(5):2642-4. PubMed ID: 17325046
    [Abstract] [Full Text] [Related]

  • 17. WHO joins battle against a new emerging disease, Buruli ulcer.
    Indian Pediatr; 1998 Jun 06; 35(6):581. PubMed ID: 10216666
    [No Abstract] [Full Text] [Related]

  • 18. [Epidemiologicl aspects of Buruli ulcer in Côte d'Ivoire: results of a national survey].
    Kanga JM, Kacou ED.
    Bull Soc Pathol Exot; 2001 Mar 06; 94(1):46-51. PubMed ID: 11346983
    [Abstract] [Full Text] [Related]

  • 19. Buruli ulcer disease in Cameroon rediscovered.
    Noeske J, Kuaban C, Rondini S, Sorlin P, Ciaffi L, Mbuagbaw J, Portaels F, Pluschke G.
    Am J Trop Med Hyg; 2004 May 06; 70(5):520-6. PubMed ID: 15155984
    [Abstract] [Full Text] [Related]

  • 20. Protective efficacy of a DNA vaccine encoding antigen 85A from Mycobacterium bovis BCG against Buruli ulcer.
    Tanghe A, Content J, Van Vooren JP, Portaels F, Huygen K.
    Infect Immun; 2001 Sep 06; 69(9):5403-11. PubMed ID: 11500410
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.